Tan Sri Dr. Munir Majid
Dr. Munir started his illustrious career in 1978 as a leader writer for The New Straits Times Press, and progressed to become its group editor. He left NST in 1986 to become CEO of Pertanian Baring Sanwa (PBS), whose name he changed to Commerce International Merchant Bankers (CIMB), which later transformed into one of Malaysia’s leading merchant banks. He was invited by the Government of Malaysia to establish and become the first and founding Executive Chairman of the Securities Commission in 1993, where he served for two terms until 1999. Upon leaving the Securities Commission, he has served as Chairman on the BOD of reputable organisations across various industries, including Celcom Malaysia, Malaysia Airlines, Bank Muamalat Malaysia, CIMB Asean Research Institute, Institute of Strategic and International Studies (ISIS) Malaysia, and the Malaysian Chapter of the ASEAN Business Advisory Council. Dr. Munir is also an Honorary Fellow of the London School of Economics (LSE), and both started and headed its Southeast Asia International Affairs Programme. He has written for IDEAS publications and published in International Politics, a British academic journal. Tan Sri Munir was appointed the Chairman of ICMR in November 2019.
Dato' Dr. Nik Ramlah Mahmood
Dato Dr. Nik Ramlah Mahmood was the Deputy Chief Executive from the Securities Commission Malaysia (SC) before retiring in March 2016, having served 23 years in the organization. Prior to joining the SC, Dato Dr. Nik Mahmood was an Associate Professor at the Faculty of Law, University of Malaya. Dato' Dr. Nik is renowned for her extensive experience in areas ranging from regulatory policy, legal reform, product and market development, corporate governance, Islamic capital market and investor education and enforcement. She is currently a board member of INCEIF- the Global University of Islamic Finance and a member of its Senate. She also serves as a board member of the Securities Industry Development Corporation (SIDC), a member of the Financial Services Professionals Board (FSPB) and is a board member for Perbadanan Insurans Deposit Malaysia (PIDM). Dato’ Dr Nik also sits as a board member of several corporate boards including Pemodalan Nasional Berhad (PNB), Amanah Saham Nasional Berhad (ASNB), United Malacca Berhad, Axiata Group Berhad and Edotco Sdn. Bhd Dato' Dr. Nik Mahmood holds a First Class Honours in Law from University Malaya and a LLM and PhD from University of London. Dato' Dr. Nik Mahmood was appointed to the Board of ICMR in July 2019.
Teoh Kok Lin
Teoh Kok Lin is the founder and Chief Investment Officer of Singular Asset Management Sdn Bhd, a fund management company established in 2002, and is licensed by the Securities Commission of Malaysia. He is also the founder and Chief Investment Officer of Singular Asset Management (Singapore) Ltd, a registered fund manager with Monetary Authority of Singapore. He has over 33 years of experience in Banking, Credit and Investment with financial institutions such as Citicorp Citibank Malaysia, Barings Malaysia, HSBC Research Malaysia and UOB Kay Hian Singapore. Currently, he is an independent non-executive director at Credit Guarantee Corporation (CGC), a subsidiary of Bank Negara Malaysia and non-executive Director of Credit Bureau Malaysia. He also serves as an Alternate Member of the General Council of the National Chamber of Commerce and Industry of Malaysia, Chairman of the Digital Economy Committee and Deputy Chairman of the Socio-Economic Research Consultative Committee of the Associated Chinese Chamber of Commerce and Industry of Malaysia. He was appointed as Secretary of the Malaysian Association of Asset Managers (MAAM). Kok Lin is one of the earliest Chartered Financial Analysts (CFA) in Malaysia and is a former president of the CFA Society Malaysia. He holds a First Class Honours Double Degree in Electrical Engineering and Commerce (Finance), University of Windsor, Canada and Master of Science in Industrial Administration, Purdue University, USA. Kok Lin was appointed to the Board of ICMR in May 2021.
